CN104509766B - 铁皮石斛饮料及其制备方法 - Google Patents
铁皮石斛饮料及其制备方法 Download PDFInfo
- Publication number
- CN104509766B CN104509766B CN201410810755.8A CN201410810755A CN104509766B CN 104509766 B CN104509766 B CN 104509766B CN 201410810755 A CN201410810755 A CN 201410810755A CN 104509766 B CN104509766 B CN 104509766B
- Authority
- CN
- China
- Prior art keywords
- dendrobium candidum
- parts
- beverage
- food enrichment
- food
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 241000026010 Dendrobium candidum Species 0.000 title claims abstract description 113
- 235000013361 beverage Nutrition 0.000 title claims abstract description 52
- 238000002360 preparation method Methods 0.000 title claims abstract description 25
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims abstract description 56
- 235000013305 food Nutrition 0.000 claims abstract description 42
- 229960003080 taurine Drugs 0.000 claims abstract description 28
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims abstract description 22
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims abstract description 22
- 239000000811 xylitol Substances 0.000 claims abstract description 22
- 235000010447 xylitol Nutrition 0.000 claims abstract description 22
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims abstract description 22
- 229960002675 xylitol Drugs 0.000 claims abstract description 22
- 239000002994 raw material Substances 0.000 claims abstract description 17
- 239000003651 drinking water Substances 0.000 claims abstract description 16
- 235000020188 drinking water Nutrition 0.000 claims abstract description 16
- 239000003814 drug Substances 0.000 claims abstract description 14
- 229940079593 drug Drugs 0.000 claims abstract description 9
- 230000000295 complement effect Effects 0.000 claims abstract description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 23
- 239000000284 extract Substances 0.000 claims description 22
- 238000000605 extraction Methods 0.000 claims description 20
- 239000007788 liquid Substances 0.000 claims description 13
- 239000000706 filtrate Substances 0.000 claims description 8
- 238000001914 filtration Methods 0.000 claims description 8
- 235000016709 nutrition Nutrition 0.000 claims description 6
- 239000003795 chemical substances by application Substances 0.000 claims description 5
- 238000003756 stirring Methods 0.000 claims description 5
- 239000012535 impurity Substances 0.000 claims description 4
- 239000000203 mixture Substances 0.000 claims description 4
- 230000035764 nutrition Effects 0.000 claims description 4
- 239000012528 membrane Substances 0.000 claims description 3
- 238000001471 micro-filtration Methods 0.000 claims description 2
- 238000000926 separation method Methods 0.000 claims description 2
- 238000000108 ultra-filtration Methods 0.000 claims description 2
- AYRXSINWFIIFAE-SCLMCMATSA-N Isomaltose Natural products OC[C@H]1O[C@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O)[C@@H](O)[C@@H](O)[C@@H]1O AYRXSINWFIIFAE-SCLMCMATSA-N 0.000 claims 2
- DLRVVLDZNNYCBX-RTPHMHGBSA-N isomaltose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)C(O)O1 DLRVVLDZNNYCBX-RTPHMHGBSA-N 0.000 claims 2
- 230000000694 effects Effects 0.000 abstract description 11
- -1 oligoisomaltose Chemical compound 0.000 abstract description 8
- 238000012360 testing method Methods 0.000 description 19
- 241000699666 Mus <mouse, genus> Species 0.000 description 17
- 210000004185 liver Anatomy 0.000 description 16
- 238000011049 filling Methods 0.000 description 15
- 239000000047 product Substances 0.000 description 14
- 238000000034 method Methods 0.000 description 13
- 230000037396 body weight Effects 0.000 description 12
- 238000002474 experimental method Methods 0.000 description 12
- 238000004519 manufacturing process Methods 0.000 description 11
- 239000000463 material Substances 0.000 description 11
- 241000700159 Rattus Species 0.000 description 10
- 206010016256 fatigue Diseases 0.000 description 10
- 230000036541 health Effects 0.000 description 10
- 210000004369 blood Anatomy 0.000 description 9
- 239000008280 blood Substances 0.000 description 9
- 241001465754 Metazoa Species 0.000 description 7
- 201000010099 disease Diseases 0.000 description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- 230000006870 function Effects 0.000 description 7
- 241000894006 Bacteria Species 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 231100000753 hepatic injury Toxicity 0.000 description 6
- 239000013642 negative control Substances 0.000 description 6
- 241000607142 Salmonella Species 0.000 description 5
- 230000001476 alcoholic effect Effects 0.000 description 5
- 238000007689 inspection Methods 0.000 description 5
- 210000002784 stomach Anatomy 0.000 description 5
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- KFSLWBXXFJQRDL-UHFFFAOYSA-N Peracetic acid Chemical compound CC(=O)OO KFSLWBXXFJQRDL-UHFFFAOYSA-N 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 230000033228 biological regulation Effects 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 230000034994 death Effects 0.000 description 4
- 239000012153 distilled water Substances 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 230000002708 enhancing effect Effects 0.000 description 4
- 239000012530 fluid Substances 0.000 description 4
- 210000002966 serum Anatomy 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 150000003626 triacylglycerols Chemical class 0.000 description 4
- 238000002137 ultrasound extraction Methods 0.000 description 4
- 102100026189 Beta-galactosidase Human genes 0.000 description 3
- 235000008733 Citrus aurantifolia Nutrition 0.000 description 3
- 241001523681 Dendrobium Species 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 108010059881 Lactase Proteins 0.000 description 3
- 206010067125 Liver injury Diseases 0.000 description 3
- 235000011941 Tilia x europaea Nutrition 0.000 description 3
- PNNCWTXUWKENPE-UHFFFAOYSA-N [N].NC(N)=O Chemical compound [N].NC(N)=O PNNCWTXUWKENPE-UHFFFAOYSA-N 0.000 description 3
- 239000002390 adhesive tape Substances 0.000 description 3
- 229940024606 amino acid Drugs 0.000 description 3
- 235000001014 amino acid Nutrition 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 108010005774 beta-Galactosidase Proteins 0.000 description 3
- 238000009835 boiling Methods 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 239000013078 crystal Substances 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 238000013461 design Methods 0.000 description 3
- 206010012601 diabetes mellitus Diseases 0.000 description 3
- 230000000857 drug effect Effects 0.000 description 3
- 235000013373 food additive Nutrition 0.000 description 3
- 239000002778 food additive Substances 0.000 description 3
- 238000003304 gavage Methods 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 230000002440 hepatic effect Effects 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 229940116108 lactase Drugs 0.000 description 3
- 239000004571 lime Substances 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 238000004806 packaging method and process Methods 0.000 description 3
- 238000012856 packing Methods 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- 239000004033 plastic Substances 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 238000007789 sealing Methods 0.000 description 3
- 230000001954 sterilising effect Effects 0.000 description 3
- 230000009182 swimming Effects 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 238000010792 warming Methods 0.000 description 3
- 244000025254 Cannabis sativa Species 0.000 description 2
- 206010008874 Chronic Fatigue Syndrome Diseases 0.000 description 2
- 229920002527 Glycogen Polymers 0.000 description 2
- 241000235342 Saccharomycetes Species 0.000 description 2
- 241000607768 Shigella Species 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 231100000460 acute oral toxicity Toxicity 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 230000000996 additive effect Effects 0.000 description 2
- 229910021529 ammonia Inorganic materials 0.000 description 2
- 230000002929 anti-fatigue Effects 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 239000006286 aqueous extract Substances 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N diphenyl Chemical compound C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 2
- 238000003255 drug test Methods 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 238000013401 experimental design Methods 0.000 description 2
- 230000037406 food intake Effects 0.000 description 2
- 235000012631 food intake Nutrition 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 229940096919 glycogen Drugs 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 229910001385 heavy metal Inorganic materials 0.000 description 2
- 230000002949 hemolytic effect Effects 0.000 description 2
- 231100000234 hepatic damage Toxicity 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 238000002386 leaching Methods 0.000 description 2
- 230000008818 liver damage Effects 0.000 description 2
- 230000003908 liver function Effects 0.000 description 2
- 230000033001 locomotion Effects 0.000 description 2
- 231100000682 maximum tolerated dose Toxicity 0.000 description 2
- 208000029766 myalgic encephalomeyelitis/chronic fatigue syndrome Diseases 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 238000010791 quenching Methods 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000003014 reinforcing effect Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 239000011265 semifinished product Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 239000003765 sweetening agent Substances 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- FFRBMBIXVSCUFS-UHFFFAOYSA-N 2,4-dinitro-1-naphthol Chemical compound C1=CC=C2C(O)=C([N+]([O-])=O)C=C([N+]([O-])=O)C2=C1 FFRBMBIXVSCUFS-UHFFFAOYSA-N 0.000 description 1
- IGJQUJNPMOYEJY-UHFFFAOYSA-N 2-acetylpyrrole Chemical class CC(=O)C1=CC=CN1 IGJQUJNPMOYEJY-UHFFFAOYSA-N 0.000 description 1
- BTTWKVFKBPAFDK-LOVVWNRFSA-N 4-Androstenediol Chemical class O[C@H]1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 BTTWKVFKBPAFDK-LOVVWNRFSA-N 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 108010003415 Aspartate Aminotransferases Proteins 0.000 description 1
- 102000004625 Aspartate Aminotransferases Human genes 0.000 description 1
- 241000186000 Bifidobacterium Species 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 241001478240 Coccus Species 0.000 description 1
- 206010010144 Completed suicide Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 102000004420 Creatine Kinase Human genes 0.000 description 1
- 108010042126 Creatine kinase Proteins 0.000 description 1
- CMSMOCZEIVJLDB-UHFFFAOYSA-N Cyclophosphamide Chemical compound ClCCN(CCCl)P1(=O)NCCCO1 CMSMOCZEIVJLDB-UHFFFAOYSA-N 0.000 description 1
- LEVWYRKDKASIDU-QWWZWVQMSA-N D-cystine Chemical compound OC(=O)[C@H](N)CSSC[C@@H](N)C(O)=O LEVWYRKDKASIDU-QWWZWVQMSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- 241001269238 Data Species 0.000 description 1
- RYAHJFGVOCZDEI-UFFNCVEVSA-N Dendrobine Chemical compound C([C@H]1CC[C@@H]2[C@@]31C)N(C)[C@@H]3[C@H]1[C@@H](C(C)C)[C@@H]2C(=O)O1 RYAHJFGVOCZDEI-UFFNCVEVSA-N 0.000 description 1
- 241001076416 Dendrobium tosaense Species 0.000 description 1
- 208000017701 Endocrine disease Diseases 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 102000006395 Globulins Human genes 0.000 description 1
- 108010044091 Globulins Proteins 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 241000594394 Hedyotis Species 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 229930192392 Mitomycin Natural products 0.000 description 1
- 241001529936 Murinae Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- NWIBSHFKIJFRCO-WUDYKRTCSA-N Mytomycin Chemical compound C1N2C(C(C(C)=C(N)C3=O)=O)=C3[C@@H](COC(N)=O)[C@@]2(OC)[C@@H]2[C@H]1N2 NWIBSHFKIJFRCO-WUDYKRTCSA-N 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 208000005374 Poisoning Diseases 0.000 description 1
- 241000293869 Salmonella enterica subsp. enterica serovar Typhimurium Species 0.000 description 1
- 208000034189 Sclerosis Diseases 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 206010050208 Teratospermia Diseases 0.000 description 1
- 208000002312 Teratozoospermia Diseases 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 108010065394 aminopherase Proteins 0.000 description 1
- 230000003444 anaesthetic effect Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 210000003484 anatomy Anatomy 0.000 description 1
- 230000000675 anti-caries Effects 0.000 description 1
- 230000003356 anti-rheumatic effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000003435 antirheumatic agent Substances 0.000 description 1
- 229910052785 arsenic Inorganic materials 0.000 description 1
- RQNWIZPPADIBDY-UHFFFAOYSA-N arsenic atom Chemical compound [As] RQNWIZPPADIBDY-UHFFFAOYSA-N 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 239000002876 beta blocker Substances 0.000 description 1
- 229940097320 beta blocking agent Drugs 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000010290 biphenyl Nutrition 0.000 description 1
- 239000004305 biphenyl Substances 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 239000000498 cooling water Substances 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 229940109239 creatinine Drugs 0.000 description 1
- 108010072045 cysteic acid decarboxylase Proteins 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 229960003067 cystine Drugs 0.000 description 1
- 230000000254 damaging effect Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- RYAHJFGVOCZDEI-CZKZLRAZSA-N dendrobine Natural products O=C1O[C@@H]2[C@H](C(C)C)[C@H]1[C@H]1[C@@]3(C)[C@@H]2N(C)C[C@H]3CC1 RYAHJFGVOCZDEI-CZKZLRAZSA-N 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 229940030606 diuretics Drugs 0.000 description 1
- 231100000673 dose–response relationship Toxicity 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 208000030172 endocrine system disease Diseases 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- YQGOJNYOYNNSMM-UHFFFAOYSA-N eosin Chemical compound [Na+].OC(=O)C1=CC=CC=C1C1=C2C=C(Br)C(=O)C(Br)=C2OC2=C(Br)C(O)=C(Br)C=C21 YQGOJNYOYNNSMM-UHFFFAOYSA-N 0.000 description 1
- 210000000918 epididymis Anatomy 0.000 description 1
- 201000010063 epididymitis Diseases 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000005429 filling process Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 239000003862 glucocorticoid Substances 0.000 description 1
- 210000003714 granulocyte Anatomy 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 230000002489 hematologic effect Effects 0.000 description 1
- 210000003494 hepatocyte Anatomy 0.000 description 1
- 231100000334 hepatotoxic Toxicity 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 238000010562 histological examination Methods 0.000 description 1
- 230000003118 histopathologic effect Effects 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 230000002262 irrigation Effects 0.000 description 1
- 238000003973 irrigation Methods 0.000 description 1
- 210000004731 jugular vein Anatomy 0.000 description 1
- 238000009940 knitting Methods 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000011133 lead Substances 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 210000005228 liver tissue Anatomy 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 230000036244 malformation Effects 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 238000000386 microscopy Methods 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 229960004857 mitomycin Drugs 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 210000001616 monocyte Anatomy 0.000 description 1
- 238000010172 mouse model Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000007830 nerve conduction Effects 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 210000001562 sternum Anatomy 0.000 description 1
- 230000003637 steroidlike Effects 0.000 description 1
- 239000000021 stimulant Substances 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 235000021092 sugar substitutes Nutrition 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 239000001117 sulphuric acid Substances 0.000 description 1
- 238000000194 supercritical-fluid extraction Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 229910052718 tin Inorganic materials 0.000 description 1
- 239000011135 tin Substances 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000820 toxicity test Toxicity 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 230000004382 visual function Effects 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/38—Other non-alcoholic beverages
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
- A23L2/60—Sweeteners
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/70—Clarifying or fining of non-alcoholic beverages; Removing unwanted matter
- A23L2/72—Clarifying or fining of non-alcoholic beverages; Removing unwanted matter by filtration
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Non-Alcoholic Beverages (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
本发明提供了一种铁皮石斛饮料,由如下重量配比的原料制成的:铁皮石斛4~8份、食品营养强化剂3~8份、饮用水补足至食品营养强化剂在所述饮料中的终浓度为1~5g/100mL;其中,所述食品营养强化剂是由牛磺酸、低聚异麦芽糖、木糖醇组成的,基于所述的牛磺酸、低聚异麦芽糖、木糖醇,所述食品营养强化剂由如下重量配比的组分组成:牛磺酸1~5份、低聚异麦芽糖10~20份、木糖醇10~25份;所述的铁皮石斛以铁皮石斛干燥茎的生药量计;本发明铁皮石斛饮料功效作用明确,制备方法经济高效,产品安全可靠。
Description
(一)技术领域
本发明涉及一种饮料及其制备方法,具体涉及一种能缓解体力疲劳,对化学性肝损伤有辅助保护功能的以铁皮石斛为主要原料的饮料及其制备方法。
(二)背景技术
现代生活节奏快,工作压力大,竞争激烈,加之缺乏运动,很易出现体虚乏力,精神倦怠的症状。据WHO调查,全球有35%以上的人处于疲劳状态,中年男性人群疲劳状态达60%。疲劳可引起运动能力、工作效率降低,如得不到及时恢复,逐渐积累,还会导致“过劳”,出现“慢性疲劳综合征(Chronic Fatigue Syndrome)”、“过度训练综合症(Overtraining Syndrome)”等,使机体内分泌紊乱、免疫力下降,甚至出现器质性疾病,威胁人类健康。
化学性肝损伤也是日常生活中危害健康的常见病症,主要由化学性肝毒性物质造成。酒精、饮食不洁、熬夜、环境污染都会加重肝脏负担,致使肝脏受损。2002年数据显示,脂肪肝、酒精肝、药肝和肝硬化等肝脏疾病的发病率显著上升,达到5000万人,已经成为威胁我国人民生命健康的严重社会问题。
铁皮石斛(Dendrobium candidum Wall.ex Lindl.)又名黑节草,为兰科石斛属多年生草本植物,有益胃生津,滋阴清热之功效,被列为“中华九大仙草之首”。现代研究表明,铁皮石斛有效成分主要为石斛碱、石斛多糖、氨基酸、酚类、挥发油等,具有促消化,抗风湿,抗肿瘤,降低血糖血脂,增强免疫等作用,药理研究还表明,铁皮石斛具有良好的抗疲劳、耐缺氧的作用,且对肝损伤也有较好的改善作用。
中医学从《黄帝内经》开始就把养生防病作为主导思想,强调“防范于未然”,中药也因其在“治未病”方面的独特优势受到了人们的重视。当前中国保健品市场中药类保健品逐渐成为新宠,而以天然植物为原料的中药饮料也正日益受到青睐,成为我国一项极具市场前景和发展潜力的产业。但目前中药饮料也存在一些问题,如制备工艺不够科学、没有进行系统的药理药效学评价、添加剂过多等。因此,有必要开发一种药效明确、工艺合理、添加剂少的中药饮料。
(三)发明内容
本发明的目的是针对现有技术的不足,提供一种药效明确、工艺合理、添加剂少的铁皮石斛饮料,本发明还提供了所述铁皮石斛饮料的制备方法。
为实现上述目的,本发明采用如下技术方案:
一种铁皮石斛饮料,所述铁皮石斛饮料是由如下重量配比的原料制成的:铁皮石斛4~8份、食品营养强化剂3~8份、饮用水补足至食品营养强化剂在所述饮料中的终浓度为1~5g/100mL;其中,所述食品营养强化剂是由牛磺酸、低聚异麦芽糖、木糖醇组成的,基于所述的牛磺酸、低聚异麦芽糖、木糖醇,所述食品营养强化剂由如下重量配比的组分组成:牛磺酸1~5份、低聚异麦芽糖10~20份、木糖醇10~25份;所述的铁皮石斛以铁皮石斛干燥茎的生药量计。
其中,原料中所述的铁皮石斛是以铁皮石斛水提液的形式提供的,所述铁皮石斛水提液是通过将投料量的铁皮石斛加水以浸提或超声波提取的方式提取得到的。
优选的,所述铁皮石斛饮料是由如下重量配比的原料制成的:铁皮石斛6~7份、食品营养强化剂5~7份、饮用水补足至食品营养强化剂在所述饮料中的终浓度为2~4g/100mL;其中,所述食品营养强化剂基于所述的牛磺酸、低聚异麦芽糖、木糖醇,由如下重量配比的组分组成:牛磺酸1~5份、低聚异麦芽糖10~20份、木糖醇10~25份。
本发明所述的铁皮石斛饮料,原料中所述的铁皮石斛为兰科石斛属多年生草本植物铁皮石斛(Dendrobium candidum Wall.ex Lindl.)的新鲜茎或干燥茎,应符合《中华人民共和国药典》2010年版(一部)规定。铁皮石斛能够“强阴益精,厚肠胃,补内绝不足,平胃气,长肌肉,益智除惊,轻身延年”,即可“滋阴补肾,生血生精,肾阴足则水调木荣,肝体得养”,又可“补养胃阴,润降胃气,助脾胃生化之源,成肝气疏泄条达之性,共奏培土以荣木之用”,“滋水涵木,培土荣木,补疏兼施,如此则肝阴得复,肝体得柔,其症自除”。药理研究表明铁皮石斛能显著降低血乳酸和肌酸激酶含量,可以在提高运动耐力的同时,加快代谢产物的清除,同时通过调节机体免疫功能,促进疲劳的尽快恢复;铁皮石斛还可降低血清丙氨酸氨基转移酶、天门冬氨酸氨基转移酶和胆固醇,对慢性酒精性肝损伤模型小鼠的肝功能和肝脂代谢有一定的改善作用。
所述的食品营养强化剂是为增强营养成分而加入食品中的天然的或者人工合成的属于天然营养素范围的食品添加剂,可以改善食品感官性状,提高营养价值,且毒副作用极小,不会对人体产生危害作用,符合《食品添加剂卫生管理办法》、《营养强化剂卫生管理办法》等相关法规的规定。所述的食品营养强化剂包括但不限于氨基酸及含氮化合物、维生素类、矿物质、不饱和脂肪酸、低聚糖、膳食纤维、胆碱、软磷脂和核苷酸等。本发明中,基于所述的牛磺酸、低聚异麦芽糖、木糖醇,优选所述的食品营养强化剂由如下重量配比的组分组成:牛磺酸1~5份、低聚异麦芽糖10~20份、木糖醇10~25份。
所述的牛磺酸是一种含硫的非蛋白氨基酸,具有提高神经传导和视觉机能、防止心血管疾病、改善内分泌状态、增强免疫抗疲劳等功效,在体内虽不参与蛋白的合成,但却与胱氨酸、半胱氨酸的代谢密切相关,而人体合成牛磺酸的半胱亚磺酸脱羧酶活性较低,因此在食物中添加一定量的牛磺酸可以满足机体的需求。
所述的低聚异麦芽糖和木糖醇作为甜味剂和营养剂在食品、医药等工业中广泛应用:低聚异麦芽糖能有效地促进人体内有益细菌--双歧杆菌的生长繁殖,且具有水溶性膳食纤维的作用,产热值很低,适于肥胖病人及糖尿病患者食用,同时它还有不胀肚、易溶于水、口感好等特点,有利于人体的健康;木糖醇具有改善肝功能、防龋齿、促双歧菌增殖、稳定胰岛素和激素水平等功能,是适合糖尿病患者食用的营养性的食糖代替品。
本发明还提供了一种所述的铁皮石斛饮料的制备方法,所述的制备方法按如下步骤进行:
(1)备料:铁皮石斛除杂,按照配方的重量比例分别称取铁皮石斛4~8份、食品营养强化剂3~8份;其中,所述食品营养强化剂基于所述的牛磺酸、低聚异麦芽糖、木糖醇,由如下重量配比的组分组成:牛磺酸1~5份、低聚异麦芽糖10~20份、木糖醇10~25份;
(2)浸提:将步骤(1)称取的铁皮石斛压裂后装入多功能提取罐,加入水使原料浸没,于95~100℃下进行提取,同时,开启多功能提取罐挥发油冷凝器,提取完成后收集冷凝液和提取液;
(3)配制:将步骤(1)称取的食品营养强化剂、步骤(2)收集的冷凝液加入步骤(2)合并所得提取液中,搅拌,补足饮用水使得食品营养强化剂的终浓度为1~5g/100mL,然后加热至95~100℃,保温搅拌30分钟,得到配制的混合液;
(4)过滤;将步骤(3)所得混合液过滤,所得滤液即为所述的铁皮石斛饮料。
本发明所述的制备方法,原料铁皮石斛经过除杂,压裂的预处理后,再装入多功能提取罐进行提取。经过预处理的铁皮石斛的质量标准是:性状为铁皮石斛茎均裂开,无杂质,色泽呈淡青灰色,味淡,略带青草气。
本发明所述的制备方法,步骤(2)除了采用所述的浸提方式,还可以采用超声波、微波、超临界流体萃取或半仿生提取等方法对铁皮石斛进行提取。铁皮石斛中主要活性成分为水溶性粗多糖,因此优选浸提或超声波提取。
所述的超声波提取方法为:将步骤(1)称取的铁皮石斛装入超声波提取机,加入水于20~60℃下进行提取,同时,通过冷凝系统回收冷凝液,提取完成后收集冷凝液和提取液。
以铁皮石斛多糖和甘露糖的转移率为指标,同时考虑生产消耗和成本,通过正交实验对浸提和超声波提取工艺进行优化,其中,对于浸提过程,优选的提取条件为:用水提取1~4次,每次提取所用的水的质量是铁皮石斛质量的5~10倍,每次提取的时间为1~2h。特别优选的提取条件为:提取2次,每次提取所用的水的质量是铁皮石斛质量的6~8倍,每次提取的时间为1h,温度为95℃。
对于超声波提取过程,优选的提取条件为:超声提取1~3次,每次提取所用的水的质量是铁皮石斛质量的6~12倍,每次提取的时间为0.5~1h,频率为20~100kHz。特别优选的提取条件为:超声提取2次,每次提取所用的水的质量是铁皮石斛质量的6~7倍,每次提取的时间为0.5h,温度为40℃,频率为60~80 kHz。
本发明所述的制备方法,步骤(3)配制所得混合液的质量标准是:混合液为淡黄色至棕黄色,澄清透明无杂质,pH值4.0~6.0,糖度≥5。
本发明所述的制备方法,步骤(4)所述的过滤方式可以采用板框过滤机过滤、离心蝶式分离、微滤或超滤等。优选采用成本低、工人劳动强度低且环保的板框过滤机过滤,所述板框过滤机参数优选为:流速5~8m3/h,压力≤0.3Mpa,滤膜孔径≤5μm。滤过后滤液呈淡黄绿色,清澈透明。
制备得到本发明所述的铁皮石斛饮料后,通过下述步骤进一步包装成可贩卖的饮料成品:
(a)容器准备:可以使用的饮料容器包括但不限于金属罐、塑料瓶、玻璃瓶和纸盒包装等;优选的,以阻隔性能优良,机械性能良好,携带方便,易于回收的金属罐和透明度高,机械强度可靠,容量大的聚酯塑料瓶作为饮料容器;容器经灭菌、清洗后,干燥备用或输送至灌装机自动灌装;
(b)灌装:调机完成后灌装的前两个样品应进行首检,检查表面是否有油污、体积、pH及糖度等指标,合格后开始灌封,灌装规格100~500mL/罐(瓶);灌装工序首检的质量标准为:表面无油污,pH值4.0~6.0,糖度≥5;
(c)灭菌:金属罐装饮料采用以下方式灭菌:将灌装后的半成品置灭菌锅中,按灭菌锅操作规程操作,逐渐升温至121℃,保温15分钟,至温度、时间到达限定值后,关闭蒸汽阀,内部的压力因温度下降而逐渐下降,至压力降至零后,慢慢打开灭菌锅盖,取出;塑料瓶装饮料采用以下方式灭菌:滤液在灌装前即进行超高温瞬时(UHT)灭菌,温度125~145℃,时间1~15秒;
(d)包装:在罐(瓶)体贴上已打印生产批号、生产日期及公司名称的标签,之后按包装规格计数装箱,胶带封箱,箱面贴物料标签,标明生产批号、生产日期等内容。
本发明所制得的铁皮石斛饮料的功效成分的含量标准为:粗多糖(以葡萄糖计)≥0.3g/100mL;牛磺酸≥0.3g/100mL。
本发明所述的铁皮石斛饮料具有解渴、改善肠道功能、促消化、增强免疫等功效,药理实验也表明,本发明所述的铁皮石斛饮料可以缓解体力疲劳,对化学性肝损伤具有辅助保护功能,可作为解渴或缓解疲劳的日常饮品,也可用于化学性肝损伤病人日常辅助治疗。
本发明所述的铁皮石斛饮料和现有技术相比具有以下优点:
(1)本发明所述的铁皮石斛饮料功效作用明确,可以缓解体力疲劳,对化学性肝损伤具有辅助保护功能;铁皮石斛益胃生津,滋阴清热,风味清新甘甜,健康自然;食品添加剂少,且添加的牛磺酸、低聚异麦芽糖和木糖醇毒副作用极小,同时它们还具有增强免疫抗疲劳、促双歧菌增殖促消化、适于肥胖及糖尿病患者食用等优点;
(2)本发明所述的铁皮石斛饮料的制备方法通过多指标正交实验优化,设计合理,可操作性强,提取效率高,且制备方法成本低、环保、可控,利于实现工业化大生产;同时,本发明所述的制备方法操作规范,质量监控严格,确保了产品的安全性和可靠性。
(四)具体实施方式
根据下述实施例,可以更好地理解本发明。然而,本领域的技术人员容易理解,实施例所描述的具体的物料配比、工艺条件及其结果仅用于说明本发明,而不应当也不会限制权利要求书中所详细描述的本发明。
实施例1
铁皮石斛饮料的制备方法,具体包括以下步骤:
(1)称取新鲜铁皮石斛茎段50份,挑选除去杂草、霉变者,将茎压裂后准备进行提取;
(2)将步骤(1)压裂的新鲜铁皮石斛茎段装入多功能提取罐,第一次加饮用水500份,升温至微沸后保温(95-100℃)1.5小时,同时开启多功能提取罐挥发油冷凝器,收集冷凝液备用;第二次提取加饮用水400份,升温至微沸后保温(95-100℃)1.5小时;第三次提取加饮用水400份,升温至微沸后保温(95-100℃)1小时。合并三次提取液静置半小时;
(3)称取牛磺酸5份、低聚异麦芽糖20份、木糖醇20份,与步骤(2)所得铁皮石斛冷凝液一起,加入步骤(2)所得提取液中,搅拌,用饮用水定容至1300份,其中食品营养强化剂的终浓度为3.5g/100mL,加热至95-100℃保温搅拌30分钟,检查PH及糖度(可溶性固形物),应符合质量要求;
(4)经步骤(3)配制后的提取液用板框过滤机过滤(8m3/h、压力≤0.3Mpa,滤膜孔径≤5μm),滤液呈淡黄绿色,清澈透明,即为所述的铁皮石斛饮料;
通过下述步骤,可将铁皮石斛饮料包装成可贩卖的饮料成品:
(a)将空罐用清水喷洗三遍至内外洁净后,纯化水荡洗一遍,倒放于盘中,沥干,经传递窗进入洁净区后用鼓风干燥箱烘干备用;
(b)调机完成后灌装的前两罐饮料应进行首检,检查表面是否有油污、体积、pH及糖度,合格后开始趁热灌封,灌装规格200ml/罐;
(c)将灌装后的半成品置灭菌锅中,按灭菌锅操作规程操作,逐渐升温至温度121℃,保温15分钟,至温度、时间到达限定值后,关闭蒸汽阀,内部的压力因温度下降而逐渐下降,至压力降至零后,慢慢打开灭菌锅盖,取出;
(d)在罐体贴上已打印生产批号、生产日期及公司名称的标签,之后按包装规格计数装箱,胶带封箱,箱面贴物料标签,标明生产批号、生产日期等内容。
按以上所述方法即可制得铁皮石斛罐装饮料成品6500份。
实施例2
铁皮石斛饮料的制备方法,具体包括以下步骤:
(1)称取铁皮石斛茎段20份,挑选除去杂草、霉变者,将茎压裂后准备进行提取;
(2)将步骤(1)中压裂的铁皮石斛茎段投入超声波提取机,第一次加饮用水200份,40℃、60 kHz超声提取1小时;第二次提取加饮用水120份,同样在40℃、40 kHz超声提取半小时;通过冷凝系统回收冷凝液,合并2次提取液静置半小时;
(3)称取牛磺酸3份、低聚异麦芽糖10份、木糖醇12份,与步骤(2)所得铁皮石斛冷凝液一起,加入步骤(2)所得提取液中,搅拌,用饮用水定容至500份,其中食品营养强化剂的终浓度为5g/100mL,加热至95-100℃保温搅拌30分钟,检查PH及糖度(可溶性固形物),应符合质量要求;
(4)经步骤(3)配制后的提取液用板框过滤机过滤(8m3/h、压力≤0.3Mpa,滤膜孔径≤5μm),滤液呈淡黄绿色,清澈透明,即为所述的铁皮石斛饮料;
通过下述步骤,可将铁皮石斛饮料包装成可贩卖的饮料成品:(a)将塑料瓶用灌装机灌满0.3%过氧乙酸消毒液,运行2-3分钟,消毒后用无菌水冲洗空瓶2次,瓶盖过醋酸消毒后用无菌水冲洗;
(b)用板式UHT对滤液杀菌,温度130℃,时间5秒,料液出口温度92℃;
(c)采用三合一灌装机进行灌装,调机完成后灌装的前两罐饮料应进行首检,检查表面是否有油污、体积、pH及糖度,合格后开始趁热灌封,灌装规格360ml/罐,灌装后倒瓶,时间50秒,灌装后瓶子进入喷淋机,时间13分钟,热水温度70℃,喷淋时间3分钟,冷却水40℃;
(d)在瓶体贴上已打印生产批号、生产日期及公司名称的标签,之后按包装规格计数装箱,胶带封箱,箱面贴物料标签,标明生产批号、生产日期等内容。
按以上所述方法即可制得铁皮石斛瓶装饮料成品1100份。
实施例3
功效成分、卫生学检测及稳定性实验
取实施例1所得铁皮石斛罐装饮料,采用苯酚-硫酸法和衍生化-高效液相色谱法(GB/T 5009.169-2003)测定饮料中粗多糖(以葡萄糖计)和牛磺酸含量。结果表明,粗多糖含量0.4克/100毫升,牛磺酸含量0.35克/100毫升,符合企业标准及食品安全国家标准的规定。
对实施例1所得铁皮石斛罐装饮料中可溶性固形物、重金属(砷、铅、铜、锌、铁、锡)、菌落总数、大肠菌群、霉菌、酵母菌、沙门氏菌、志贺氏菌、金黄色葡萄球菌、溶血性链球菌等进行了检测,结果表明,可溶性固形物含量为5.86%,各类重金属未检出或满足相应标准要求,菌落总数、大肠菌群、霉菌、酵母菌在规定值以下,沙门氏菌、志贺氏菌、金黄色葡萄球菌、溶血性链球菌未检出,饮料卫生指标安全、优异,符合控制标准要求。
对实施例1所得铁皮石斛罐装饮料在37~40℃和75%湿度条件下保温3个月,于0、1、2、3月份分别对样品进行包括感官指标、功效成分及上述卫生学各项指标进行全项目检测,结果显示样品稳定性良好,符合企业标准规定。
实施例4
兴奋剂检测实验
取实施例1所得铁皮石斛罐装饮料,按YYB-101-FD2012、YYB-102-FD2012、YYB-103-FD2012、YYB-104-FD2012、YYB-105-FD2012和YYB-106-FD2012等方法(国家兴奋剂检测研究中心),对安屈非尼等66种刺激剂、可待因等19种麻醉剂、雄烯二醇等89种甾体、乙酰唑胺等22种利尿剂、阿普洛尔等20种β-阻断剂、沙丁胺醇等13种β2-激动剂、阿那曲唑等42种糖皮质激素和优克那非等13种功能性药物进行检测。结果表明,铁皮石斛饮料中未检出上述兴奋剂。
实施例5
大鼠30天喂养毒性试验
实施例1所得铁皮石斛罐装饮料,按生药量计算料每罐含9克铁皮石斛,相当于0.702克铁皮石斛提取物,推荐剂量为200毫升/60公斤/天。实验设计三个剂量组,分别相当于人摄入剂量的25、50、100倍。实验时将低聚麦芽糖和木糖醇按产品浓度配制成基液,按上述3个比例添加铁皮石斛提取物和牛磺酸,用基液稀释成不同浓度供试。
SD大鼠80只,随机分为4组,每组20只,雌雄各半。单笼饲养,自由进食、饮水。连续灌胃给药30天,每周记录一次体重和两次进食量,计算食物利用率。实验期末称取末次体重(第4周体重)后动物禁食过夜。次日称空腹体重后颈静脉取血。分别用全自动血细胞分析仪和全自动生化分析仪测定血液学和血生化指标。所有动物做大体解剖,称重,并进行病理组织学检查。
采用SPSS11.5对数据进行统计分析,先对数据作方差齐性检验。方差齐,采用单因素方差分析进行总体比较,有差异时,再与对照组作均数间两两比较。方差不齐时对原始数据进行转换,满足方差齐性检验,用转换的数据进行统计。转换后不能满足方差齐性的,改用秩和检验。
结果表明,实验期间,各组大鼠均未见异常症状和体征,也无死亡。实验各时间点各剂量组大鼠体重、进食量、食物利用率与阴性对照组比较差异均无显著性(P>0.05)。各剂量组大鼠血红蛋白、红细胞、白细胞、淋巴细胞、单核细胞和粒细胞等血液学指标,谷丙转氨酶、谷草转氨酶、尿素氮、肌酐、胆固醇、甘油三酯、血糖、总蛋白、白蛋白、球蛋白等血生化指标,空腹体重、脏器重、脏体比也无显著性差异(P>0.05)。大鼠病理组织学检查发现各器官形态正常,各组间未发现明显差异。
综上所述,本次实验结果表明铁皮石斛饮料30天喂养实验各剂量组各项指标均未见明显毒性反应。
实施例6
大鼠、小鼠鼠急性经口毒性试验,Ames试验、小鼠微核试验、小鼠精子畸形试验
采用最大耐受剂量法,设样品15.0g/kg体重一个剂量组,取铁皮石斛提取物和牛磺酸,按实施例1中饮料中相应比例混合成受试物,配成0.25g/mL(可灌胃最大浓度),按20mL/kg体重三次灌胃给予,间隔4小时,分别考察大鼠和小鼠的急性经口毒性;Ames试验菌株选择组氨酸营养缺陷型鼠伤寒沙门氏菌TA97、TA98、TAl00、TA102。代谢活化系统(S9)为多氯联苯诱导SD大鼠获得的肝匀浆上清液,试验采用平板掺入法,取受试物加灭菌蒸馏水配置成不同剂量,并设空白对照组、溶剂对照组(H2O)和阳性对照组,每种菌株每个测试浓度设三皿平行,在加S9和不加S9条件下进行试验,观察指标为直接计数培养基上各菌株的回变菌落数;骨髓细胞微核试验设置低、中、高三个剂量组和蒸馏水阴性对照组与环磷酰胺阳性对照组。采用间隔24小时给予小鼠样品,末次给样品后6小时处死动物,取其胸骨骨髓制片,甲醇固定,Giemsa染色;精子畸形试验组别设计与微核实验相同(阳性药为丝裂霉素),连续给药5天,首次给药35天后取附睾剪碎,涂片,干燥,甲醇固定,用1%伊红染色。用高倍镜检查精子形态,计算精子畸形率(%)。
实验结果表明,观察期内未见实验大鼠或小鼠出现中毒症状和死亡情况,表明该样品大、小鼠,雌雄性急性经口最大耐受剂量均大于15.0g/kg体重;不同剂量受试物在加S9和不加S9条件下的回变菌落数均未超过空白对照组、溶剂对照组回变菌落数的两倍,且各剂量组间无明显的剂量反应关系,表明该样品Ames试验结果为阴性;各剂量组微核率、精子畸形率和阴性对照组比较,差异均无显著性(P>0.05),该样品小鼠微核试验、精子畸形实验结果均为阴性。
实施例7
缓解体力疲劳功能实验
实施例1所得铁皮石斛罐装饮料,按生药量计算料每罐含9克铁皮石斛,相当于0.702克铁皮石斛提取物。实验设计三个剂量组,分别相当于人摄入剂量的5、10、30倍。实验时按上述3个比例添加铁皮石斛提取物和牛磺酸,用蒸馏水稀释成不同浓度供试。分别采用负重游泳试验、血清尿素氮测定、肝糖原测定和血乳酸测定来进行药效评价。
实验结果表明,各剂量组小鼠在实验初期、中期和末期体重和阴性对照组相比差异均无显著性(P>0.05);与阴性对照组相比,低、中剂量组可明显提高小鼠负重游泳时间,差异具有显著性(P<0.05);中剂量组能明显降低小鼠运动后血清尿素氮含量(P<0.05);中、高剂量组均能显著降低小鼠游泳后血乳酸含量和血乳酸曲线下面积(P<0.05);各剂量组小鼠肝糖原含量与阴性对照组相比,差异无显著性(P>0.05)。
综上所述,铁皮石斛饮料具有缓解体力疲劳的作用。
实施例8
实施例1所得铁皮石斛罐装饮料,按生药量计算料每罐含9克铁皮石斛,相当于0.702克铁皮石斛提取物。设置低、中、高三个剂量组,分别相当于人摄入剂量的5、10、30倍。实验时按上述3个比例添加铁皮石斛提取物和牛磺酸,用蒸馏水稀释成不同浓度供试。采用酒精肝损伤模型法,于实验的第30天将模型对照组、各剂量组动物一次灌胃给予50%乙醇(12mL/kg),空白对照组动物给蒸馏水,禁食16h处死动物,取肝脏进行各项指标的检测及病理组织学检查。
结果表明,低、中、高三剂量组增重和模型对照组比较差异均无显著性(P>0.05)。三剂量组小鼠初始体重、中期体重、终期体重和模型对照组比较均无显著性差异(P>0.05);与空白对照组比较,模型对照组小鼠肝组织丙二醛(MDA)、甘油三酯(TG)明显升高,差异有显著性(P<0.01),说明酒精肝损伤模型成立;与模型对照组比较,高剂量组小鼠肝组织TG、MDA含量均明显降低,差异均有显著性(P<0.05);肝脏病理组织学变化显示,模型对照组与各剂量组动物肝脏病理改变以肝细胞脂肪变性为主,病变部位以小叶周边带多见;与空白对照组比较,模型对照组小鼠肝脏细胞脂肪变性得分均值明显升高,差异有显著性(P<0.01),说明酒精肝损伤模型成立。与模型对照组比较,高剂量组小鼠肝脏细胞脂肪变性得分均值明显降低,差异有显著性(P<0.05)。
综上所述,铁皮石斛饮料对小鼠酒精肝损伤有辅助保护作用。
以上实施方式只为说明本发明的技术构思及特点,其目的在于让熟悉此项技术的人了解本发明内容并加以实施,并不能以此限制本发明的保护范围,凡根据本发明精神实质所做的等效变化或修饰,都应涵盖在本发明的保护范围内。
Claims (6)
1.一种铁皮石斛饮料,其特征在于,所述铁皮石斛饮料是由如下重量配比的原料制成的:铁皮石斛4~8份、食品营养强化剂3~8份、饮用水补足至食品营养强化剂在所述饮料中的终浓度为1~5g/100mL;所述食品营养强化剂由如下重量配比的组分组成:牛磺酸1~5份、低聚异麦芽糖10~20份、木糖醇10~25份;所述的铁皮石斛以铁皮石斛干燥茎的生药量计;
原料铁皮石斛是铁皮石斛的新鲜茎;
所述铁皮石斛饮料的制备方法按如下步骤进行:
(1)备料:铁皮石斛除杂,按照配方的重量比例分别称取铁皮石斛4~8份、食品营养强化剂3~8份;其中,所述食品营养强化剂由如下重量配比的组分组成:牛磺酸1~5份、低聚异麦芽糖10~20份、木糖醇10~25份;
(2)浸提:将步骤(1)称取的铁皮石斛压裂后装入多功能提取罐,加入水使原料浸没,于95~100℃下进行提取,同时,开启多功能提取罐挥发油冷凝器,提取完成后收集冷凝液和提取液;
(3)配制:将步骤(1)称取的食品营养强化剂、步骤(2)所得冷凝液加入步骤(2)所得提取液中,搅拌,补足饮用水使得食品营养强化剂的终浓度为1~5g/100mL,然后加热至95~100℃,保温搅拌30分钟,得到配制的混合液;
所述混合液为淡黄色至棕黄色,澄清透明无杂质,pH4.0~6.0,糖度≥5;
(4)过滤:将步骤(3)所得混合液过滤,所得滤液即为所述的铁皮石斛饮料。
2.如权利要求1所述的铁皮石斛饮料,其特征在于,所述铁皮石斛饮料是由如下重量配比的原料制成的:铁皮石斛6~7份、食品营养强化剂5~7份、饮用水补足至食品营养强化剂在所述饮料中的终浓度为2~4g/100mL;其中,所述食品营养强化剂由如下重量配比的组分组成:牛磺酸1~5份、低聚异麦芽糖10~20份、木糖醇10~25份。
3.一种权利要求1所述的铁皮石斛饮料的制备方法,其特征在于,所述的制备方法按如下步骤进行:
(1)备料:铁皮石斛除杂,按照配方的重量比例分别称取铁皮石斛4~8份、食品营养强化剂3~8份;其中,所述食品营养强化剂由如下重量配比的组分组成:牛磺酸1~5份、低聚异麦芽糖10~20份、木糖醇10~25份;
(2)浸提:将步骤(1)称取的铁皮石斛压裂后装入多功能提取罐,加入水使原料浸没,于95~100℃下进行提取,同时,开启多功能提取罐挥发油冷凝器,提取完成后收集冷凝液和提取液;
(3)配制:将步骤(1)称取的食品营养强化剂、步骤(2)所得冷凝液加入步骤(2)所得提取液中,搅拌,补足饮用水使得食品营养强化剂的终浓度为1~5g/100mL,然后加热至95~100℃,保温搅拌30分钟,得到配制的混合液;
所述混合液为淡黄色至棕黄色,澄清透明无杂质,pH4.0~6.0,糖度≥5;
(4)过滤:将步骤(3)所得混合液过滤,所得滤液即为所述的铁皮石斛饮料。
4.如权利要求3所述的铁皮石斛饮料的制备方法,其特征在于,步骤(2)所述的浸提过程中,用水提取1~4次,每次提取所用的水的质量是铁皮石斛质量的5~10倍,每次提取的时间为1~2h。
5.如权利要求3~4之一所述的铁皮石斛饮料的制备方法,其特征在于,步骤(4)所述的过滤方式为:采用板框过滤机过滤、离心蝶式分离、微滤或超滤。
6.如权利要求5所述的铁皮石斛饮料的制备方法,其特征在于,步骤(4)所述的过滤方式为采用板框过滤机过滤,所述板框过滤机参数为:流速5~8m3/h,压力≤0.3Mpa,滤膜孔径≤5μm。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410810755.8A CN104509766B (zh) | 2014-12-23 | 2014-12-23 | 铁皮石斛饮料及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410810755.8A CN104509766B (zh) | 2014-12-23 | 2014-12-23 | 铁皮石斛饮料及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104509766A CN104509766A (zh) | 2015-04-15 |
CN104509766B true CN104509766B (zh) | 2017-10-10 |
Family
ID=52786073
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410810755.8A Active CN104509766B (zh) | 2014-12-23 | 2014-12-23 | 铁皮石斛饮料及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104509766B (zh) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105285641A (zh) * | 2015-11-26 | 2016-02-03 | 黄桂月 | 一种铁皮石斛饮品的制备方法 |
CN105816258A (zh) * | 2016-03-11 | 2016-08-03 | 永胜玉水农特开发有限责任公司 | 种鸡的人工授精方法 |
CN106260240A (zh) * | 2016-08-10 | 2017-01-04 | 孔令娇 | 一种新型铁皮石斛茶醋饮料 |
CN108142766A (zh) * | 2018-03-12 | 2018-06-12 | 杨素华 | 一种铁皮石斛饮料及其制备方法 |
CN108522734A (zh) * | 2018-05-04 | 2018-09-14 | 文山学院 | 一种铁皮石斛花茶饮料及其制备方法 |
CN109380632A (zh) * | 2018-10-31 | 2019-02-26 | 杭州鑫伟低碳技术研发有限公司 | 一种雨生红球藻虾青素和铁皮石斛的饮料及其制备方法 |
CN110934187B (zh) * | 2019-10-09 | 2023-01-17 | 湖南凤凰兰科中药材股份有限公司 | 一种低糖铁皮石斛保健酸奶及其制备方法 |
EP4074188A1 (en) * | 2021-04-15 | 2022-10-19 | Compagnie Gervais Danone | A process of preparing a beverage with natural plant infusions |
CN115669835A (zh) * | 2022-11-11 | 2023-02-03 | 广州市东鹏食品饮料有限公司 | 一种灵芝铁皮石斛抗疲劳饮料 |
CN117530380A (zh) * | 2023-12-13 | 2024-02-09 | 大冶康之堂农业发展有限公司 | 一种具有肠道调节功效的复合饮料及其制备方法 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101557096B1 (ko) * | 2008-05-23 | 2015-10-20 | 서희동 | 해양 심층수로부터 차 음료제조용수를 생산하는 방법과이를 차 음료제조에 이용하는 방법 |
CN101744334B (zh) * | 2008-12-09 | 2012-07-04 | 杨军 | 一种具有石斛成分的保健饮料 |
CN102240058B (zh) * | 2011-08-16 | 2013-09-04 | 熊书银 | 一种石斛饮料及其制备方法 |
CN102987394A (zh) * | 2012-12-06 | 2013-03-27 | 广东光宇生物科技有限公司 | 具有增强免疫力的参斛保健食品及其制备方法 |
CN104083636A (zh) * | 2014-06-17 | 2014-10-08 | 江苏益草堂石斛股份有限公司 | 一种增强免疫的铁皮石斛组合物及其制备方法 |
-
2014
- 2014-12-23 CN CN201410810755.8A patent/CN104509766B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN104509766A (zh) | 2015-04-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104509766B (zh) | 铁皮石斛饮料及其制备方法 | |
CN103725469B (zh) | 一种养生干红葡萄酒 | |
KR20120014712A (ko) | 여주를 주원료로 한 혈당강하용 기능성 음료와 차 및 이의 제조방법 | |
CN102671009A (zh) | 植物发酵提取物及其粉末以及其组合物的制造方法 | |
JP2017509636A (ja) | 後発酵茶抽出物を含む組成物 | |
CN102551065A (zh) | 一种降糖食品系列 | |
CN102994350A (zh) | 一种具有降血脂功能苦荞酒的制备方法 | |
KR20120116374A (ko) | 혈당강하용 기능성 여주음료의 제조방법 | |
CN101082018B (zh) | 一种黄酒的生产方法 | |
CN106138101B (zh) | 一种鸡胚胎提取物的制备方法 | |
CN109757638A (zh) | 一种铁皮石斛植物饮料的制备方法 | |
CN102421299A (zh) | 含有发酵茶的血液循环改善用组合物以及含有该组合物的药物组合物和保健食品组合物 | |
CN105462793B (zh) | 一种保健药酒其制备方法 | |
KR101394358B1 (ko) | 숙취 해소용 조성물 | |
CN101880624A (zh) | 一种仁用杏果肉酿制果醋的方法 | |
CN105012826B (zh) | 一种益智叶提取物及其制备方法、应用 | |
CN107266596A (zh) | 一种无花果多糖及其制备方法和应用 | |
CN107557254A (zh) | 一种荔枝玫瑰酒和制备方法及补益气血与抗氧化应用 | |
KR102536812B1 (ko) | 장수만리화 추출물을 포함하는 항알러지용 조성물 | |
CN104435349B (zh) | 具有醒酒保肝作用的组合物及其制备方法和应用 | |
CN103859515A (zh) | 一种葛根、樱桃复合饮料及其制备方法 | |
CN107502509A (zh) | 一种低酒精含量覆盆子保健酒饮料及其制备方法 | |
CN103555527B (zh) | 蛇肽保健酒及其制备方法 | |
KR102192586B1 (ko) | 아위버섯의 추출물 또는 분말을 유효성분으로 함유하는 지방간 질환 치료용 약학적 조성물 및 간기능 개선용 건강기능식품 | |
Sintyadewi et al. | Analysis of chemical characteristics and antioxidant activity test of kombucha black tea and butterfly pea flower (Clitoria ternatea L.) based on fermentation time |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |